688581 Stock Overview

Engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China. More details

688581 fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	4/6
Past Performance	5/6
Financial Health	6/6
Dividends	3/6

Rewards

Trading at 50.3% below our estimate of its fair value

Earnings are forecast to grow 22.3% per year

Earnings grew by 44.2% over the past year

Trading at good value compared to peers and industry

Risk Analysis

No risks detected for 688581 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Hangzhou AGS MedTech Co., Ltd. Competitors

Dirui IndustrialLtd

SZSE:300396

CN¥4.7b

Xiangyu MedicalLtd

SHSE:688626

CN¥4.9b

Shanghai Aohua Photoelectricity Endoscope

SHSE:688212

CN¥5.5b

SWS Hemodialysis Care

SHSE:688410

CN¥3.6b

Price History & Performance

Summary of share price highs, lows and changes for HangzhouS MedTech
Historical stock prices
Current Share Price	CN¥61.57
52 Week High	CN¥74.88
52 Week Low	CN¥46.83
Beta	0
1 Month Change	0.77%
3 Month Change	15.36%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	12.25%

Recent updates

Shareholder Returns

	688581	CN Medical Equipment	CN Market
7D	0.3%	-0.6%	-1.0%
1Y	n/a	-9.6%	10.8%

Return vs Industry: Insufficient data to determine how 688581 performed against the CN Medical Equipment industry.

Return vs Market: Insufficient data to determine how 688581 performed against the CN Market.

Price Volatility

Is 688581's price volatile compared to industry and market?
688581 volatility
688581 Average Weekly Movement	7.5%
Medical Equipment Industry Average Movement	8.6%
Market Average Movement	8.8%
10% most volatile stocks in CN Market	13.0%
10% least volatile stocks in CN Market	5.8%

Stable Share Price: 688581 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 688581's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2010	672	Cheng Zhang	www.bioags.com

Hangzhou AGS MedTech Co., Ltd. engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China. It offers hemoclips; bipolar generators, CR4500 CO2 regulation units, and UW600-II water pumps; disposable stone extraction baskets, nasal biliary drainage catheters, sphincterotomes, disposable guide wires, and stone retrieval balloons; disposable bipolar ESD knives, polypectomy snares, and disposable sclerotherapy needles; and disposable grasping forceps and disposable biopsy forceps. The company was founded in 2010 and is based in China.

Hangzhou AGS MedTech Co., Ltd. Fundamentals Summary

How do HangzhouS MedTech's earnings and revenue compare to its market cap?
688581 fundamental statistics
Market cap	CN¥4.95b
Earnings (TTM)	CN¥271.52m
Revenue (TTM)	CN¥590.12m

18.2x

P/E Ratio

8.4x

P/S Ratio

Is 688581 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688581 income statement (TTM)
Revenue	CN¥590.12m
Cost of Revenue	CN¥162.79m
Gross Profit	CN¥427.34m
Other Expenses	CN¥155.82m
Earnings	CN¥271.52m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	3.37
Gross Margin	72.41%
Net Profit Margin	46.01%
Debt/Equity Ratio	0%

How did 688581 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

31%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/25 06:54
End of Day Share Price	2024/12/25 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hangzhou AGS MedTech Co., Ltd. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Shuo Song	Citic Securities Co., Ltd.
Yin Ye	Ping An Securities Co. Ltd.